Cargando…
Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients
The outcomes of advanced non-small cell lung cancer (NSCLC) patients have been significantly improved with novel therapies, such as tyrosine kinase inhibitors and immune checkpoint inhibitors. However, in resource-limited countries, platinum-doublet chemotherapy is mainly used as a first-line treatm...
Autores principales: | Chayangsu, Chawalit, Khorana, Jiraporn, Charoentum, Chaiyut, Sriuranpong, Virote, Patumanond, Jayanton, Tantraworasin, Apichat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914574/ https://www.ncbi.nlm.nih.gov/pubmed/36766868 http://dx.doi.org/10.3390/healthcare11030293 |
Ejemplares similares
-
Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer
por: Tantraworasin, Apichat, et al.
Publicado: (2013) -
Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
por: Tantraworasin, Apichat, et al.
Publicado: (2013) -
The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival
por: Tantraworasin, Apichat, et al.
Publicado: (2013) -
Clinical Prediction Scoring Scheme for 24 h Mortality in Major Traumatic Adult Patients
por: Samuthtai, Waratsuda, et al.
Publicado: (2022) -
Clinical Score for Predicting the Risk of Poor Ambulation at Discharge in Fragility Femoral Neck Fracture Patients: A Development Study
por: Tangchitphisut, Paween, et al.
Publicado: (2022)